Blog

Dr Choo Su Pin on ongoing Phase III EMERALD-1 study for cancer patients with intermediate stage HCC

The global study explores the efficacy and safety of transarterial chemoembolization (TACE) treatment in combination with durvalumab monotherapy or TACE with durvalumab plus bevacizumab therapy.
Cara Yap
7 April 2021

Oncoshot in TechNode Global feature on health-tech start-ups driving innovation in the face of Covid-19

The regional media outlet highlighted Oncoshot's contributions in fostering a more collaborative, data-driven cancer clinical trial landscape.
Cara Yap
11 March 2021

PRECISE CURATE.AI trial: Dr Dean Ho and Dr Raghav Sundar on pilot study exploring guided dosing with XELOX, XELIRI and single agent capecitabine to treat solid tumours

The Phase I and II single-arm pilot study with multiple cohorts of patient populations harnesses AI for personalised guidance of an individual’s dose modulations based only on his/her data. It aims to re-look at the way oncology clinical trials are designed.
Cara Yap
1 March 2021

How to ensure successful cancer clinical trial enrolment

Tech-powered solutions such as data-driven pre-screening tools can enable more accurate feasibility studies, thus improving cancer clinical trial enrolment rates.
Cara Yap
25 February 2021

Liver cancer trial: Dr Toh Han Chong on ongoing study using Atezolizumab plus Bevacizumab to lower recurrence risk in patients with hepatocellular carcinoma

He leads a Phase III, randomised, open-label study of Atezolizumab plus Bevacizumab versus active surveillance as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after surgical resection or ablation.
Cara Yap
7 January 2021

Breast cancer trial: Dr Yap Yoon Sim on why ongoing clinical trial is significant for patients with PIK3CA-mutant, hormone receptor-positive, Her2-negative, locally advanced or metastatic breast cancer

The phase III, randomised, double-blind, placebo-controlled study evaluates the efficacy and safety of GDC-0077 plus palbociclib and fulvestrant versus placebo plus palbociclib and fulvestrant in patients who meet the specific trial criteria.
Cara Yap
11 December 2020

Oncoshot wins at Technode Global Origin Innovation Awards 2020

Oncoshot won in the Healthtech category of the Startup Awards, which honour regional startups that embody the spirit of innovation and entrepreneurship.
Cara Yap
19 November 2020

Oncoshot introduces new cancer clinical trial notification service

The free service is designed to help busy oncologists identify promising cancer clinical trials for their patients in an efficient manner.
Cara Yap
19 November 2020

What are clinical trials and just how important are they in cancer care?

With cancer continuing to be a leading cause of mortality worldwide, cutting-edge cancer clinical trials can help you expand your treatment options.
Dr Huren Sivaraj
2 November 2020

Breast cancer: know your screening and treatment options

In light of Breast Cancer Awareness month in October, we highlight potentially live-saving detection methods and new therapies - including those you may access through clinical trials.
Cara Yap
7 October 2020